On december 20th, the guangdong drug trading centre published a document on the procurement of chinese medicines such as the guangdong union golden lotus capsule, and published the highest prices for 40 types of medicines such as the golden lotus, blue slunt, orange red skin, and polytoxin。
The daily people's daily health client reporter found that the highest average daily cost/ceiling price of the medium medicine involved in the collection was €0. 7747 per day for the chorus, and the highest price was £137. 025 per day for eddie injection. The maximum selection daily cost/ceiling price for most medicines is less than $20. The maximum daily average cost/ceiling price for a gold-love capsule is us$ 3,3918 per day, the child coughing granule (no sugar type) is us$ 2. 6,727 per day and the cerebral tremor capsule is us$ 7. 821 per day。
At the same time, there are a number of species with a maximum average daily cost/ceiling price above $50. For example, the maximum selection daily average cost/ceiling price is $69. 2336 for the daily meadow injection, 52. 377 for thermal intoxication injection, and $90. 6268 for the daily paralysing positive injection。
In addition, the prices of different types of medicines vary from one type to the same. For example, the maximum selection daily cost/ceiling price for the formulation type of the film was $0. 7747 per day, while for the agent type of aerosol it was $61. 62 per spray. Similarly, the mascara is $1. 8 per day and the injection fluid is $69. 2336。
Why is the price of chinese medicine very different? The relevant head of the national health insurance agency explained that “one may differ from the same name's medium-medicine composition, for example, an oral dose of an arterial fluid, which also has a beneficial effect on gas and vulcanization, and the cost of the artery with red gin is higher than the cost of the artery with party participation; the other is that, unlike the same drug type, the price of drip pills and soft capsules is generally higher than that of ordinary capsules; and the third is that there may be differences in the quality standards of different enterprises, some of which are higher than those of other enterprises, and the price of their products is higher”
It is understood that the current centralized drug lead procurement cycle is in principle to 31 december 2026, calculated from the actual implementation date of the successful result and the first year of purchase to 31 december 2025. Upon expiration of the procurement cycle, the procurement period may be extended, in principle, by 12 months, depending on the circumstances, such as procurement and supply. The specific time of implementation of each of the federal provinces (districts, municipalities) is determined by the province (districts, municipalities)。
